patient talking to doctor

Virtual CME Program

1.00 CME/CE Credit

Learning Through Understanding: Helping You Explain Things Quickly to Patients

This session uses simple visuals and analogies to explain complex physiology quickly and clearly to patients. Learners will gain practical tools for turning dense pathophysiology into memorable, actionable conversations that improve patient understanding, adherence, and shared decision-making.

Begin

CME/CE Information

1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.00 AANP, including 0.33 AANP Pharm

Release Date: 9/18/2026

Expiration Date: 10/18/2026

Learning Objectives

  • Explain the physiological mechanisms behind obesity, insulin resistance, and sedentary behavior using simple visual analogies patients can readily grasp
  • Describe how SGLT2 inhibitors and GLP-1 receptor agonists protect the kidney, heart, and metabolic function, and translate these mechanisms into patient-friendly language
  • Apply simplified explanatory tools for discussing various pathophysiologic mechanisms to improve patient comprehension and engagement

Faculty

Peter Lin, MD, CCFP

Director Primary Care Initiatives, Canadian Heart Research Centre

Past Associate Editor, Elsevier WebPortal - PracticeUpdate Primary Care

Medical Director LinCorp Medical Inc.

Learn More

Disclosures

The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All relevant relationships have been mitigated by Pri-Med Institute:

Peter Lin, MD, CCFP: Speaker for Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GSK, HLS Therapeutics, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Reckitt, and Sanofi.

Pamela Kushner, MD, FAAFP (Moderator): Advisor for Abbott, AstraZeneca, Bausch + Lomb/Salix, Boehringer Ingelheim, Corcept, GSK, Haleon, and Novo Nordisk. Speaker for Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Corcept, Eli Lilly, GSK, Haleon, Janssen, and Novo Nordisk.

All others in control of content for this activity have disclosed no relevant financial relationships.

CME/CE Information

AMA PRA Category 1 Credits

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308. 

 

Designation Statement

This activity is approved for 1.00 contact hour of continuing education (which includes 0.33 hours of pharmacology).

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, and 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

ABP combined

Instructions for Obtaining Credit

Once you have completed the activity, please click the "Next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of the 3 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

Learning Through Understanding: Helping You Explain Things Quickly to Patients

Begin